Cortex
- Company typePrivate
- Founded2023
- HeadquartersMenlo Park, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Cortex firmographics
Firmographics- Name
- Cortex
- Legal name
- Cortex, Inc.
- Website
- https://cortexep.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Cortex industry classification
Industry- Product category
- Cardiac Electrophysiology Mapping Systems
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Electrophysiology Mapping & Ablation Systems (HLAHAFAD)
- akta.pro secondary industries
- Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI), Electrophysiology (Heart Rhythm) (HLAKABAC)
Keywords
Where Cortex is headquartered
LocationHeadquarters
- HQ city
- Menlo Park
- HQ country
- United States
- HQ region
- North America
Markets served
Cortex business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Cortex product offering
Product offeringCore offering
Cortex developed the OPTIMAP™ System, an advanced diagnostic cardiac mapping system that uses a proprietary electrographic flow (EGF) algorithm to identify sources, triggers, and drivers of atrial fibrillation by pinpointing areas of repeated divergent flow. The system is 510(k) cleared and is designed to integrate with the OPAL HDx mapping system and the FARAPULSE pulsed field ablation platform to support targeted, patient-specific AFib ablation procedures.
Product overview
Cortex, Inc. was a medical technology company focused on atrial fibrillation (AFib) ablation technology, originally established by Ajax Health with a $90 million investment from KKR and Hellman & Friedman in December 2023. The company's primary product was the OPTIMAP™ System, an advanced diagnostic mapping system that uses proprietary electrographic flow (EGF) algorithm to identify sources, triggers, or drivers of atrial fibrillation. In November 2024, Boston Scientific acquired Cortex, Inc. and integrated the OPTIMAP technology into its electrophysiology portfolio, combining it with the OPAL HDx Mapping System and FARAPULSE PFA platform for comprehensive AF treatment.
Differentiator
Problem solved
Functional benefit
Products and services
- OPTIMAP™ System Advanced diagnostic cardiac mapping system that uses the electrographic flow (EGF) algorithm to identify sources, triggers, or drivers of atrial fibrillation. It is intended for electrophysiologists and hospitals performing AFib ablation procedures and is designed to integrate with Boston Scientific's OPAL HDx mapping system and FARAPULSE pulsed field ablation platform. 510(k) cleared by FDA.
Quantifiable outcome
- FLOW-AF study demonstrated 51% improvement in Freedom from AF at 1 year with PVI + EGF-guided mapping and ablation versus PVI alone
Companies that use Cortex
Customer profileSegments1 record
Ideal customer profiles1 record
Cortex technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature2 records
Cortex partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Boston ScientificflagshipBoston Scientific acquired Cortex, Inc. to obtain the OPTIMAP System with electrographic flow (EGF) algorithm technology for advanced AF diagnostic mapping. The technology will integrate with Boston Scientific's OPAL HDx mapping system and FARAPULSE PFA platform to support comprehensive atrial fibrillation treatment.
Scale indicators1 record
Recent moves5 records
Expansion highlights4 records
Cortex competitors and assessment
Company assessmentDirect peers
- Acutus Medical: Acutus Medical developed the AcQMap non-contact mapping system for AFib, directly competing with Cortex's OPTIMAP in advanced diagnostic cardiac mapping for atrial arrhythmias.
Broad incumbents
- Biosense Webster (Johnson & Johnson): Biosense Webster's CARTO 3 mapping system is the market-leading EP mapping platform; its SmartTouch catheter and AI-based annotation tools compete with OPTIMAP's EGF-guided workflow.
- Abbott: Abbott's EnSite X EP mapping system competes directly with OPTIMAP in the cardiac mapping space, offering HD Grid and AI-enabled mapping features for AF ablation procedures.
- Boston Scientific: Boston Scientific's OPAL HDx mapping system and FARAPULSE PFA platform are the parent platforms that now integrate OPTIMAP; OPAL HDx is a direct mapping-system peer.
- Medtronic (Affera): Medtronic's Affera mapping and ablation system (acquired 2022) competes with OPTIMAP in integrated mapping and ablation for AF, particularly the Sphere-9 catheter workflow.
Emerging players
- Volta Medical: Volta Medical offers AI-driven real-time mapping decision support for AF ablation, overlapping with OPTIMAP's goal of identifying patient-specific arrhythmia mechanisms for targeted treatment.
- Kardium: Kardium is developing the Globe PF mapping and ablation system, an emerging integrated catheter that combines mapping with PFA for AF treatment, competing with Boston Scientific's integrated OPTIMAP + FARAPULSE workflow.
- CathVision: CathVision provides AI-enabled EP signal recording and 3D cardiac mapping technology, overlapping with the signal-processing and AI capabilities of OPTIMAP's EGF and LUMIPOINT modules.
- Adagio Medical: Adagio Medical develops ultra-low temperature cryoablation for AF, including mapping-integrated workflows for persistent AF, making it a partial competitor in the advanced AF ablation space where OPTIMAP's EGF guidance is used.
Regional players
- AtriCure: AtriCure is a competitor in the AF treatment space, focused on surgical and hybrid ablation approaches; while its modality differs from catheter-based mapping, it competes for the same AF patient pool and EP/surgical referral channels.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Cortex social profiles
Digital presenceCortex financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cortex leadership team
Management profileNumber of profiles
Profiles1 record
Cortex funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cortex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cortex
What does Cortex do?
Cortex developed the OPTIMAP™ System, an advanced diagnostic cardiac mapping system that uses a proprietary electrographic flow (EGF) algorithm to identify sources, triggers, and drivers of atrial fibrillation by pinpointing areas of repeated divergent flow. The system is 510(k) cleared and is designed to integrate with the OPAL HDx mapping system and the FARAPULSE pulsed field ablation platform to support targeted, patient-specific AFib ablation procedures.
Is Cortex a public or private company?
Cortex is a private company. It is classified as corporate owned and is currently acquired.
When was Cortex founded?
Cortex was founded in 2023. It employs 11 to 50 people.
Where is Cortex based?
Cortex is headquartered in Menlo Park, United States, in the North America region.
Who are Cortex's main competitors?
Acutus Medical is listed as a direct peer. Broad incumbents are Biosense Webster (Johnson & Johnson), Abbott, Boston Scientific and Medtronic (Affera). Emerging players are Volta Medical, Kardium, CathVision and Adagio Medical. AtriCure is listed as a regional player.
Does Cortex have an API?
No public API is recorded for Cortex.
What industry is Cortex in?
Cortex's product category is Cardiac Electrophysiology Mapping Systems. Its primary akta.pro industry code is HLAHAFAD, Electrophysiology Mapping & Ablation Systems, with a secondary code of HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT). Its NAICS code is 334510 and its SIC code is 3845.